共 21 条
[1]
Identification and characterization of mutations in hepatitis B virus resistant to Lamivudine. Allex M L,Deslauriers M,Andrews C W,et al. Hepatology . 1998
[2]
Overlapping gene mutations of hepatitis B virus in a chronic hepatitis B patient with hepatitis B surface antigen loss during lamivudine therapy. Lee SY,Choi MS,Lee D,et al. Journal of Korean Medical Science . 2005
[3]
Clearance of the original hepatitis B virus YMDD-motif mutants with emergence of distinct lamivudine-resistant mutants during prolonged lamivudine therapy. Yeh CT,Chien RN,Chu CM,et al. Hepatology . 2000
[5]
YSDD:a no-vel mutation in HBVDNApolymerase confers clinical resistance to lamivudine. Bozdayi AM,Uzunalimoglu O,Turkyilmaz AR,et al. Journal of Viral Hepatitis . 2003
[6]
The polymerase L528M muta-tion cooperates with nucleotide binding-site mutations,increasing hepatitis B virus replication and drug resistance. Ono SK,Kato N,Shiratori Y,et al. The Journal of Clinical Investigation . 2001
[7]
Emer-gence of a novel lamivudine-resistant hepatitis B virus va-riant with a substitution outside the YMDD motif. YATSUJI H,NOGUCHI C,HIRAGA N,et al. Antimicrobial Agents and Chemotherapy . 2006
[8]
Variant of hepatitis B virus with primary resistance to adefovir. Schildgen O,Sirma H,Funk A,Olotu C,Wend UC,Hart- mann H,Helm M,Rockstroh JK,Willems WR,Will H,Gerlich WH. N Engl J Med . 2006
[9]
Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to Lamivudine. Tenney DJ,Levine SM,Rose RE,et al. Antimicrobial Agents and Chemotherapy . 2004
[10]
Ente-cavir resistance is rare in nucleoside naive patients with hepatitis B. COLONNO RJ,ROSE R,BALDICK CJ,et al. Hepatology . 2006